These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 36867344)
21. New advances of microRNAs in glioma stem cells, with special emphasis on aberrant methylation of microRNAs. Zhao B; Bian EB; Li J; Li J J Cell Physiol; 2014 Sep; 229(9):1141-7. PubMed ID: 24374932 [TBL] [Abstract][Full Text] [Related]
22. A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice. Holland EC; Hively WP; DePinho RA; Varmus HE Genes Dev; 1998 Dec; 12(23):3675-85. PubMed ID: 9851974 [TBL] [Abstract][Full Text] [Related]
23. Cell of origin determines tumor phenotype in an oncogenic Ras/p53 knockout transgenic model of high-grade glioma. Ghazi SO; Stark M; Zhao Z; Mobley BC; Munden A; Hover L; Abel TW J Neuropathol Exp Neurol; 2012 Aug; 71(8):729-40. PubMed ID: 22805776 [TBL] [Abstract][Full Text] [Related]
24. Ets Factors Regulate Neural Stem Cell Depletion and Gliogenesis in Ras Pathway Glioma. Breunig JJ; Levy R; Antonuk CD; Molina J; Dutra-Clarke M; Park H; Akhtar AA; Kim GB; Hu X; Bannykh SI; Verhaak RG; Danielpour M Cell Rep; 2015 Jul; 12(2):258-71. PubMed ID: 26146073 [TBL] [Abstract][Full Text] [Related]
25. TERT promoter mutations lead to high transcriptional activity under hypoxia and temozolomide treatment and predict poor prognosis in gliomas. Chen C; Han S; Meng L; Li Z; Zhang X; Wu A PLoS One; 2014; 9(6):e100297. PubMed ID: 24937153 [TBL] [Abstract][Full Text] [Related]
26. Therapeutic efficacy of PUMA for malignant glioma cells regardless of p53 status. Ito H; Kanzawa T; Miyoshi T; Hirohata S; Kyo S; Iwamaru A; Aoki H; Kondo Y; Kondo S Hum Gene Ther; 2005 Jun; 16(6):685-98. PubMed ID: 15960600 [TBL] [Abstract][Full Text] [Related]
27. Gliomagenesis and the use of neural stem cells in brain tumor treatment. Achanta P; Sedora Roman NI; Quiñones-Hinojosa A Anticancer Agents Med Chem; 2010 Feb; 10(2):121-30. PubMed ID: 20184546 [TBL] [Abstract][Full Text] [Related]
28. Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice. Friedmann-Morvinski D; Bushong EA; Ke E; Soda Y; Marumoto T; Singer O; Ellisman MH; Verma IM Science; 2012 Nov; 338(6110):1080-4. PubMed ID: 23087000 [TBL] [Abstract][Full Text] [Related]
29. Nrf2-driven TERT regulates pentose phosphate pathway in glioblastoma. Ahmad F; Dixit D; Sharma V; Kumar A; Joshi SD; Sarkar C; Sen E Cell Death Dis; 2016 May; 7(5):e2213. PubMed ID: 27148686 [TBL] [Abstract][Full Text] [Related]
30. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Dai C; Celestino JC; Okada Y; Louis DN; Fuller GN; Holland EC Genes Dev; 2001 Aug; 15(15):1913-25. PubMed ID: 11485986 [TBL] [Abstract][Full Text] [Related]
31. H3.3 Pathania M; De Jay N; Maestro N; Harutyunyan AS; Nitarska J; Pahlavan P; Henderson S; Mikael LG; Richard-Londt A; Zhang Y; Costa JR; Hébert S; Khazaei S; Ibrahim NS; Herrero J; Riccio A; Albrecht S; Ketteler R; Brandner S; Kleinman CL; Jabado N; Salomoni P Cancer Cell; 2017 Nov; 32(5):684-700.e9. PubMed ID: 29107533 [TBL] [Abstract][Full Text] [Related]
32. An inducible mouse model for skin cancer reveals distinct roles for gain- and loss-of-function p53 mutations. Caulin C; Nguyen T; Lang GA; Goepfert TM; Brinkley BR; Cai WW; Lozano G; Roop DR J Clin Invest; 2007 Jul; 117(7):1893-901. PubMed ID: 17607363 [TBL] [Abstract][Full Text] [Related]
33. Quantification, self-renewal, and genetic tracing of FL1⁺ tumor-initiating cells in a large cohort of human gliomas. Clément-Schatlo V; Marino D; Burkhardt K; Teta P; Leyvraz F; Schatlo B; Frank S; Schaller K; Castella V; Radovanovic I Neuro Oncol; 2012 Jun; 14(6):720-35. PubMed ID: 22584872 [TBL] [Abstract][Full Text] [Related]
34. CPEB1, a histone-modified hypomethylated gene, is regulated by miR-101 and involved in cell senescence in glioma. Xiaoping L; Zhibin Y; Wenjuan L; Zeyou W; Gang X; Zhaohui L; Ying Z; Minghua W; Guiyuan L Cell Death Dis; 2013 Jun; 4(6):e675. PubMed ID: 23788032 [TBL] [Abstract][Full Text] [Related]
35. Regulated ATF5 loss-of-function in adult mice blocks formation and causes regression/eradication of gliomas. Arias A; Lamé MW; Santarelli L; Hen R; Greene LA; Angelastro JM Oncogene; 2012 Feb; 31(6):739-51. PubMed ID: 21725368 [TBL] [Abstract][Full Text] [Related]
36. Molecular Characteristics of Thalamic Gliomas in Adults. Wang T; Niu X; Gao T; Zheng L; Qiu Y; Mao Q J Mol Neurosci; 2021 Aug; 71(8):1598-1604. PubMed ID: 33523385 [TBL] [Abstract][Full Text] [Related]
37. Cell type-specific tumor suppression by Ink4a and Arf in Kras-induced mouse gliomagenesis. Uhrbom L; Kastemar M; Johansson FK; Westermark B; Holland EC Cancer Res; 2005 Mar; 65(6):2065-9. PubMed ID: 15781613 [TBL] [Abstract][Full Text] [Related]
38. A drosophila model for EGFR-Ras and PI3K-dependent human glioma. Read RD; Cavenee WK; Furnari FB; Thomas JB PLoS Genet; 2009 Feb; 5(2):e1000374. PubMed ID: 19214224 [TBL] [Abstract][Full Text] [Related]
39. Association of Telomerase Reverse Transcriptase Promoter Mutations with the Prognosis of Glioma Patients: a Meta-Analysis. Wang X; Li X; Xu F; Zhang Y; Liu H; Tao Y Mol Neurobiol; 2016 May; 53(4):2726-32. PubMed ID: 26351078 [TBL] [Abstract][Full Text] [Related]
40. C/EBPβ deletion in oncogenic Ras skin tumors is a synthetic lethal event. Messenger ZJ; Hall JR; Jima DD; House JS; Tam HW; Tokarz DA; Smart RC Cell Death Dis; 2018 Oct; 9(11):1054. PubMed ID: 30323292 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]